These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 16498700)
1. Is there a case for using visual analogue scale valuations in cost-utility analysis? Parkin D; Devlin N Health Econ; 2006 Jul; 15(7):653-64. PubMed ID: 16498700 [TBL] [Abstract][Full Text] [Related]
2. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC; Value Health; 2009; 12(5):750-8. PubMed ID: 19490564 [TBL] [Abstract][Full Text] [Related]
3. An experimental test of a theoretical foundation for rating-scale valuations. Bleichrodt H; Johannesson M Med Decis Making; 1997; 17(2):208-16. PubMed ID: 9107617 [TBL] [Abstract][Full Text] [Related]
4. A social preference valuations set for EQ-5D health states in Flanders, Belgium. Cleemput I Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490 [TBL] [Abstract][Full Text] [Related]
5. Re-scaling social preference data: implications for modelling. Cleemput I; Kind P; Kesteloot K Eur J Health Econ; 2004 Dec; 5(4):290-8. PubMed ID: 15759169 [TBL] [Abstract][Full Text] [Related]
6. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study. Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ; BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068 [TBL] [Abstract][Full Text] [Related]
7. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Griebsch I; Coast J; Brown J Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026 [TBL] [Abstract][Full Text] [Related]
8. QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Heintz E; Wiréhn AB; Peebo BB; Rosenqvist U; Levin LÅ Value Health; 2012 May; 15(3):475-84. PubMed ID: 22583458 [TBL] [Abstract][Full Text] [Related]
9. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods. Yusof FA; Goh A; Azmi S Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073 [TBL] [Abstract][Full Text] [Related]
10. Quality of life utilities for pelvic inflammatory disease health states. Smith KJ; Tsevat J; Ness RB; Wiesenfeld HC; Roberts MS Sex Transm Dis; 2008 Mar; 35(3):307-11. PubMed ID: 18032995 [TBL] [Abstract][Full Text] [Related]
11. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values. Dolan P; Sutton M Soc Sci Med; 1997 May; 44(10):1519-30. PubMed ID: 9160441 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and reliability of a mailed questionnaire to obtain visual analogue scale valuations for health states defined by the Health Utilities Index Mark 3. Raat H; Bonsel GJ; Hoogeveen WC; Essink-Bot ML; Med Care; 2004 Jan; 42(1):13-8. PubMed ID: 14713735 [TBL] [Abstract][Full Text] [Related]
13. The performance of a value set for the EQ-5D based on experienced health states in patients with inflammatory bowel disease. Leidl R; Reitmeir P; König HH; Stark R Value Health; 2012 Jan; 15(1):151-7. PubMed ID: 22264983 [TBL] [Abstract][Full Text] [Related]
14. Economic evaluation in schistosomiasis: valuation of health states preferences. A research note. Kirigia JM Health Econ; 1998 Sep; 7(6):551-6. PubMed ID: 9809712 [TBL] [Abstract][Full Text] [Related]
15. Modelling valuations for health states: the effect of duration. Dolan P Health Policy; 1996 Dec; 38(3):189-203. PubMed ID: 10162421 [TBL] [Abstract][Full Text] [Related]
16. Utilities derived from visual analog scale scores in patients with HIV/AIDS. Mrus JM; Yi MS; Freedberg KA; Wu AW; Zackin R; Gorski H; Tsevat J Med Decis Making; 2003; 23(5):414-21. PubMed ID: 14570299 [TBL] [Abstract][Full Text] [Related]
17. Productivity costs in health-state valuations : does explicit instruction matter? Krol M; Brouwer W; Sendi P Pharmacoeconomics; 2006; 24(4):401-14. PubMed ID: 16605285 [TBL] [Abstract][Full Text] [Related]
18. A multi-method approach to measuring health-state valuations. Salomon JA; Murray CJ Health Econ; 2004 Mar; 13(3):281-90. PubMed ID: 14981652 [TBL] [Abstract][Full Text] [Related]
19. A preference-based index for the SF-12. Stratmann-Schoene D; Kuehn T; Kreienberg R; Leidl R Health Econ; 2006 Jun; 15(6):553-64. PubMed ID: 16389653 [TBL] [Abstract][Full Text] [Related]
20. Use of the visual analogue scale for health state valuation: a scoping review. Åström M; Thet Lwin ZM; Teni FS; Burström K; Berg J Qual Life Res; 2023 Oct; 32(10):2719-2729. PubMed ID: 37029258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]